Skip to main content
Top
Published in: International Cancer Conference Journal 2/2018

Open Access 01-04-2018 | Case report

Successful radiotherapy for endometrial serous carcinoma with local repeated recurrence

Authors: Shinya Kusumoto, Hisaya Fujiwara, Maiko Sagawa, Takahiro Nobuzane, Toshihiro Nishida, Yukio Akagi, Yutaka Hirokawa, Yasuhiro Katsube

Published in: International Cancer Conference Journal | Issue 2/2018

Login to get access

Abstract

The incidence of endometrial serous carcinoma (ESC) has been increasing, and ESC is resistant to treatment. We report a patient with ESC who responded to radiotherapy for multiple recurrences. The first recurrence was detected in the vaginal wall and left internal iliac lymph node 5 months after the initial treatment. Concurrent chemoradiotherapy (CCRT) was administered. Radiation was delivered using the intensity modulated radiation therapy technique. The second recurrent tumor was detected in the right internal iliac lymph node after 4 months, and CCRT was conducted. After 4 months, the third recurrence was detected in the right common iliac node, and CCRT was performed. After 8 months, the fourth recurrence was detected in the horizontal portion of the duodenum, and radiotherapy was administered. After 9 months, the fifth recurrence was detected in the vaginal wall. Interstitial brachytherapy was conducted. Grade 2 gastrointestinal injury, nausea and radiodermatitis were observed. During the subsequent 13-month follow-up, there has been no recurrence. Although ESC is resistant to treatment, radiotherapy could be effective in some cases. Even when multiple recurrences occur, radiotherapy may be considered a treatment option if the irradiation level is permissible.
Literature
1.
go back to reference JSOG (2010) Annual report of endometrial cancer, 2008. Acta Obstet Gynaecol Jpn 62:853–876 JSOG (2010) Annual report of endometrial cancer, 2008. Acta Obstet Gynaecol Jpn 62:853–876
2.
go back to reference Slomovitz BM, Burke TW, Eifel PJ et al (2003) Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol 91:463–469CrossRefPubMed Slomovitz BM, Burke TW, Eifel PJ et al (2003) Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol 91:463–469CrossRefPubMed
3.
go back to reference Menderes G, Clark M, Santin AD (2016) Novel targeted therapies in uterine serous carcinoma, an aggressive variant of endometrial cancer. Discov Med 116:293–303 Menderes G, Clark M, Santin AD (2016) Novel targeted therapies in uterine serous carcinoma, an aggressive variant of endometrial cancer. Discov Med 116:293–303
4.
go back to reference Curran WJ Jr, Whittington R, Peters AJ et al (1998) Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system. Int J Radiat Oncol Biol Phys 15:803–808CrossRef Curran WJ Jr, Whittington R, Peters AJ et al (1998) Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system. Int J Radiat Oncol Biol Phys 15:803–808CrossRef
5.
go back to reference Sears JD, Greven KM, Hoen HM et al (1994) Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer. Cancer 74:1303–1308CrossRefPubMed Sears JD, Greven KM, Hoen HM et al (1994) Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer. Cancer 74:1303–1308CrossRefPubMed
6.
go back to reference Jhingran A, Burke TW, Eifel PJ et al (2003) Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 56:1366–1372CrossRefPubMed Jhingran A, Burke TW, Eifel PJ et al (2003) Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 56:1366–1372CrossRefPubMed
7.
go back to reference Wylie J, Irwin C, Pintilie M et al (2000) Results of radical radiotherapy for recurrent endometrial cancer. Gynecol Oncol 77:66–72CrossRefPubMed Wylie J, Irwin C, Pintilie M et al (2000) Results of radical radiotherapy for recurrent endometrial cancer. Gynecol Oncol 77:66–72CrossRefPubMed
9.
go back to reference Miyanaga S, Ninomiya I, Tsukada T et al (2016) Concentration-dependent radiosensitizing effect of docetaxel in esophageal squamous cell carcinoma cells. Int J Oncol 48:517–524CrossRefPubMed Miyanaga S, Ninomiya I, Tsukada T et al (2016) Concentration-dependent radiosensitizing effect of docetaxel in esophageal squamous cell carcinoma cells. Int J Oncol 48:517–524CrossRefPubMed
10.
go back to reference Torres K, Horwitz SB (1998) Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res 58:3620–3626PubMed Torres K, Horwitz SB (1998) Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res 58:3620–3626PubMed
11.
go back to reference Hernández-Vargas H, Palacios J, Moreno-Bueno G (2007) Telling cells how to die: docetaxel therapy in cancer cell lines. Cell Cycle 6:780–783CrossRefPubMed Hernández-Vargas H, Palacios J, Moreno-Bueno G (2007) Telling cells how to die: docetaxel therapy in cancer cell lines. Cell Cycle 6:780–783CrossRefPubMed
12.
go back to reference Zhang D, Yang R, Wang S et al (2014) Paclitaxel: New uses for an old drug. Drug Des Dev Ther 8:279–284 Zhang D, Yang R, Wang S et al (2014) Paclitaxel: New uses for an old drug. Drug Des Dev Ther 8:279–284
13.
go back to reference Seiwert TY, Salama JK, Vokes EE (2007) The concurrent chemoradiation paradigm—general principles. Nat Clin Pract Oncol 4:86–100CrossRefPubMed Seiwert TY, Salama JK, Vokes EE (2007) The concurrent chemoradiation paradigm—general principles. Nat Clin Pract Oncol 4:86–100CrossRefPubMed
16.
17.
go back to reference Shirvani SM, Klopp AH, Likhacheva A et al (2013) Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer. Pract Radiat Oncol 3:21–28CrossRef Shirvani SM, Klopp AH, Likhacheva A et al (2013) Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer. Pract Radiat Oncol 3:21–28CrossRef
Metadata
Title
Successful radiotherapy for endometrial serous carcinoma with local repeated recurrence
Authors
Shinya Kusumoto
Hisaya Fujiwara
Maiko Sagawa
Takahiro Nobuzane
Toshihiro Nishida
Yukio Akagi
Yutaka Hirokawa
Yasuhiro Katsube
Publication date
01-04-2018
Publisher
Springer Japan
Published in
International Cancer Conference Journal / Issue 2/2018
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-018-0323-4

Other articles of this Issue 2/2018

International Cancer Conference Journal 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine